10.08.2012
- AstraZeneca has opted to pay a further $135 million to Bristol-Myers Squibb to get an equal say in decision-making regarding drugs developed by Amylin Pharmaceuticals, the diabetes...
26.07.2012
- Europe's sick economy is infecting its pharmaceuticals sector, traditionally one of the region's most successful industries. Price cuts to rein in healthcare spending reached...
19.07.2012
- Business in Great Britain - Since 2008, the UK chemical industry has gone through one of the biggest downturns in production of all the world's leading producers of chemicals. Now...
12.07.2012
- AstraZeneca has clinched two new deals in neuroscience, underlining the drugmaker's increasing reliance on external projects to refill a sparse pipeline as it tests a new low-cost...
30.06.2012
- Simon Lowth may only be the interim chief executive of AstraZeneca but he is ready to sign off on bold deals. The decision to pair up with Bristol-Myers Squibb to buy diabetes...
27.06.2012
- Swiss drugmaker Roche said on Tuesday it was overhauling its research operations by closing the 80-year-old New Jersey facility where Valium was discovered, cutting 1,000 jobs and...
02.06.2012
- AstraZeneca and Bristol-Myers Squibb are among several pharmaceutical giants that have submitted initial bids for Amylin Pharmaceuticals, the diabetes drugmaker that is exploring a...
01.06.2012
- AstraZeneca's new chairman took the helm on Friday and said the troubled drugmaker faced "a period of significant change". Leif Johansson's first priority is to find a permanent...
